Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Generated: September 17, 2019

DrugPatentWatch Database Preview

Patent: 8,216,997

Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,216,997

Title:	Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
Abstract:	In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.
Inventor(s):	Seehra; Jasbir (Lexington, MA), Pearsall; Robert Scott (Woburn, MA), Kumar; Ravindra (Acton, MA)
Assignee:	Acceleron Pharma, Inc. (Cambridge, MA)
Application Number:	12/856,420
Patent Claims:	see list of patent claims

Details for Patent 8,216,997

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Amgen	EPOGEN/PROCRIT	epoetin alfa	VIAL; SINGLE-USE	103234	001	1989-06-01	➤ Sign Up	Acceleron Pharma, Inc. (Cambridge, MA)	2029-08-13	RX		search
Amgen	EPOGEN/PROCRIT	epoetin alfa	VIAL; MULTIDOSE	103234	002	1989-06-01	➤ Sign Up	Acceleron Pharma, Inc. (Cambridge, MA)	2029-08-13	RX		search
Amgen	EPOGEN/PROCRIT	epoetin alfa	VIAL; MULTIDOSE	103234	003	1989-06-01	➤ Sign Up	Acceleron Pharma, Inc. (Cambridge, MA)	2029-08-13	RX		search
Amgen	EPOGEN/PROCRIT	epoetin alfa	VIAL; SINGLE-USE	103234	004	1989-06-01	➤ Sign Up	Acceleron Pharma, Inc. (Cambridge, MA)	2029-08-13	RX		search
Amgen	EPOGEN/PROCRIT	epoetin alfa	VIAL; SINGLE-USE	103234	005	1989-06-01	➤ Sign Up	Acceleron Pharma, Inc. (Cambridge, MA)	2029-08-13	RX		search
Amgen	EPOGEN/PROCRIT	epoetin alfa	VIAL; SINGLE-USE	103234	006	1989-06-01	➤ Sign Up	Acceleron Pharma, Inc. (Cambridge, MA)	2029-08-13	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 8,216,997

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Publication Date
Australia	2009282441	Feb 18, 2010
Australia	2009282441	Jan 22, 2015
Australia	2010282361	Mar 15, 2012
Australia	2010282361	Mar 19, 2015
Australia	2015202035	Mar 23, 2017
Australia	2015202035	May 14, 2015
>Country	>Patent Number	>Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.